7.11
price up icon2.60%   0.18
after-market After Hours: 7.07 -0.04 -0.56%
loading
Corvus Pharmaceuticals Inc stock is traded at $7.11, with a volume of 1.08M. It is up +2.60% in the last 24 hours and up +21.96% over the past month. Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).
See More
Previous Close:
$6.93
Open:
$7.27
24h Volume:
1.08M
Relative Volume:
1.72
Market Cap:
$529.79M
Revenue:
-
Net Income/Loss:
$-27.03M
P/E Ratio:
-12.70
EPS:
-0.56
Net Cash Flow:
$-23.97M
1W Performance:
+1.86%
1M Performance:
+21.96%
6M Performance:
+138.59%
1Y Performance:
+12.32%
1-Day Range:
Value
$7.03
$7.51
1-Week Range:
Value
$6.39
$7.51
52-Week Range:
Value
$2.54
$10.00

Corvus Pharmaceuticals Inc Stock (CRVS) Company Profile

Name
Name
Corvus Pharmaceuticals Inc
Name
Phone
(650) 900-4520
Name
Address
863 MITTEN ROAD, BURLINGAME, CA
Name
Employee
31
Name
Twitter
Name
Next Earnings Date
2025-03-25
Name
Latest SEC Filings
Name
CRVS's Discussions on Twitter

Compare CRVS with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
CRVS
Corvus Pharmaceuticals Inc
7.11 516.38M 0 -27.03M -23.97M -0.56
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
407.37 104.55B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
464.95 60.36B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
557.73 59.84B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
799.56 49.07B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
327.03 35.16B 4.56B -176.77M 225.30M -1.7177

Corvus Pharmaceuticals Inc Stock (CRVS) Upgrades & Downgrades

Date Action Analyst Rating Change
Jan-02-25 Initiated H.C. Wainwright Buy
Aug-18-23 Initiated Oppenheimer Outperform
Dec-01-21 Resumed Jefferies Buy
May-27-21 Initiated Cantor Fitzgerald Overweight
Feb-10-21 Downgrade Mizuho Buy → Neutral
Sep-12-19 Initiated Mizuho Buy
May-29-19 Initiated ROTH Capital Buy
Aug-24-17 Upgrade Credit Suisse Underperform → Neutral
May-01-17 Downgrade Credit Suisse Neutral → Underperform
Apr-18-16 Initiated Credit Suisse Outperform
Apr-18-16 Initiated Guggenheim Buy
View All

Corvus Pharmaceuticals Inc Stock (CRVS) Latest News

pulisher
11:19 AM

Will Corvus Pharmaceuticals Inc. stock go up soon2025 AllTime Highs & Low Drawdown Investment Ideas - newser.com

11:19 AM
pulisher
11:14 AM

What technical models suggest about Corvus Pharmaceuticals Inc.’s comebackWatch List & Free Expert Verified Stock Movement Alerts - newser.com

11:14 AM
pulisher
09:03 AM

Should you hold or exit Corvus Pharmaceuticals Inc. nowPortfolio Update Report & Daily Profit Focused Stock Screening - newser.com

09:03 AM
pulisher
09:03 AM

Using RSI to spot recovery in Corvus Pharmaceuticals Inc.July 2025 News Drivers & Entry and Exit Point Strategies - newser.com

09:03 AM
pulisher
08:46 AM

Barclays Initiates Corvus Pharmaceuticals at Overweight With $16 Price Target - MarketScreener

08:46 AM
pulisher
08:36 AM

Barclays Initiates Coverage on CRVS with Overweight Rating | CRV - GuruFocus

08:36 AM
pulisher
06:27 AM

Barclays initiates Corvus Pharmaceuticals stock with Overweight rating - Investing.com

06:27 AM
pulisher
Oct 10, 2025

Corvus Pharmaceuticals Inc.’s volatility index tracking explainedShort Setup & Safe Entry Momentum Stock Tips - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

What analysts say about Corvus Pharmaceuticals Inc stockInsider Trading Activity & Free Lightning Fast Capital Gains - earlytimes.in

Oct 10, 2025
pulisher
Oct 10, 2025

Weiss Ratings Reaffirms "Sell (D-)" Rating for Corvus Pharmaceuticals (NASDAQ:CRVS) - MarketBeat

Oct 10, 2025
pulisher
Oct 06, 2025

Detecting support and resistance levels for Corvus Pharmaceuticals Inc.July 2025 Momentum & Verified Momentum Watchlists - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Empirical Financial Services LLC d.b.a. Empirical Wealth Management Invests $672,000 in Corvus Pharmaceuticals, Inc. $CRVS - MarketBeat

Oct 06, 2025
pulisher
Oct 05, 2025

Has Corvus Pharmaceuticals Inc. formed a bullish divergenceJuly 2025 Reactions & Breakout Confirmation Trade Signals - newser.com

Oct 05, 2025
pulisher
Oct 03, 2025

Published on: 2025-10-03 06:35:03 - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Measuring Corvus Pharmaceuticals Inc.’s beta against major indicesEarnings Miss & Community Verified Trade Signals - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Chart based exit strategy for Corvus Pharmaceuticals Inc.July 2025 Macro Moves & Advanced Technical Signal Analysis - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Candlestick signals on Corvus Pharmaceuticals Inc. stock todayWall Street Watch & Daily Stock Trend Watchlist - newser.com

Oct 03, 2025
pulisher
Oct 02, 2025

Corvus Pharmaceuticals appoints David Moore to board of directors - Investing.com

Oct 02, 2025
pulisher
Oct 02, 2025

Corvus Pharmaceuticals Appoints David Moore To Board Of Directors - TradingView

Oct 02, 2025
pulisher
Oct 02, 2025

Novo Nordisk EVP David Moore Joins Corvus Board to Advance ITK Inhibitor Platform and Commercial Strategy - Stock Titan

Oct 02, 2025
pulisher
Oct 01, 2025

Published on: 2025-10-01 07:08:07 - newser.com

Oct 01, 2025
pulisher
Sep 28, 2025

What drives Corvus Pharmaceuticals Inc stock priceStock Rotation Strategies & Low Risk Capital Appreciation - earlytimes.in

Sep 28, 2025
pulisher
Sep 27, 2025

Is Corvus Pharmaceuticals Inc a good long term investmentRisk-Reward Ratio Analysis & Tap Into the Fastest-Growing Companies - Early Times

Sep 27, 2025
pulisher
Sep 26, 2025

Corvus Pharmaceuticals (NASDAQ:CRVS) Shares Up 6.1%Should You Buy? - MarketBeat

Sep 26, 2025
pulisher
Sep 25, 2025

Are Investors Undervaluing Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) By 37%? - 富途牛牛

Sep 25, 2025
pulisher
Sep 25, 2025

While institutions invested in Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) benefited from last week's 12% gain, individual investors stood to gain the most - simplywall.st

Sep 25, 2025
pulisher
Sep 23, 2025

Is Corvus Pharmaceuticals Inc. trending in predictive chart modelsMarket Growth Report & Growth Oriented Trade Recommendations - newser.com

Sep 23, 2025
pulisher
Sep 22, 2025

What candlestick patterns are forming on Corvus Pharmaceuticals Inc.Weekly Profit Report & Free Daily Entry Point Trade Alerts - newser.com

Sep 22, 2025
pulisher
Sep 22, 2025

Is Corvus Pharmaceuticals Inc. forming a reversal patternMarket Trend Report & Reliable Intraday Trade Plans - newser.com

Sep 22, 2025
pulisher
Sep 21, 2025

How to integrate Corvus Pharmaceuticals Inc. into portfolio analysis toolsJuly 2025 Short Interest & Weekly Breakout Opportunity Watchlist - newser.com

Sep 21, 2025
pulisher
Sep 20, 2025

Moving Averages: Is Corvus Pharmaceuticals Inc undervalued by DCF analysis2025 Performance Recap & Risk Controlled Daily Trade Plans - خودرو بانک

Sep 20, 2025
pulisher
Sep 20, 2025

Using data models to predict Corvus Pharmaceuticals Inc. stock movement2025 Volatility Report & Safe Capital Growth Stock Tips - newser.com

Sep 20, 2025
pulisher
Sep 20, 2025

How to manage a losing position in Corvus Pharmaceuticals Inc.Quarterly Trade Summary & Fast Entry High Yield Tips - newser.com

Sep 20, 2025
pulisher
Sep 20, 2025

Will Corvus Pharmaceuticals Inc stock hit new highs in YEAR2025 Growth vs Value & Accurate Technical Buy Alerts - khodrobank.com

Sep 20, 2025
pulisher
Sep 19, 2025

Layoff Watch: Is Corvus Pharmaceuticals Inc undervalued by DCF analysisMarket Performance Report & Low Drawdown Investment Ideas - khodrobank.com

Sep 19, 2025
pulisher
Sep 19, 2025

Visual analytics tools that track Corvus Pharmaceuticals Inc. performanceQuarterly Trade Report & Daily Market Momentum Tracking - newser.com

Sep 19, 2025
pulisher
Sep 19, 2025

Published on: 2025-09-20 03:21:59 - خودرو بانک

Sep 19, 2025
pulisher
Sep 19, 2025

Has Corvus Pharmaceuticals Inc. found a price floorPrice Action & Daily Stock Momentum Reports - newser.com

Sep 19, 2025

Corvus Pharmaceuticals Inc Stock (CRVS) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Corvus Pharmaceuticals Inc Stock (CRVS) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Thompson Peter A.
Director
Jun 27 '25
Sale
4.16
1,176,332
4,891,894
7,165,006
Jones William Benton
See Remarks
Jun 04 '25
Option Exercise
3.50
19,357
67,750
173,130
MILLER RICHARD A MD
President and CEO
May 07 '25
Option Exercise
3.50
559,073
1,956,756
1,136,707
$84.73
price up icon 1.11%
$22.93
price up icon 7.40%
$32.68
price up icon 2.73%
$102.30
price up icon 0.24%
$163.94
price up icon 0.99%
biotechnology ONC
$327.03
price up icon 2.16%
Cap:     |  Volume (24h):